Impact Factor
2.97
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.15
204 total citations
h5-index
20
h5 depth signal
Cited share
61.9%
60 of 97
Total citations
204
Citation footprint
Metric signal
2.34
External metric anchor
Self-citation
10.8%
22 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Greece
226
United States
95
Italy
86
China
79
United Kingdom
61
Citing Fields of Research
Cardiology
313
Diabetes
138
Lipids
85
Vascular Disorders
73
Kidney Diseases
55
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,656
Articles tracked across the journal lifetime
Indexed publication set
97
60 cited publications
Last 12 months
50
5.6 publications/month
Open access share
4.0%
2 OA publications in the last year
Leading citing country
Greece
226 citing publications
Leading citing field
Cardiology
313 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Mar. 2003-
v1n1, Mar. 2003-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Broad Categories
Pharmacology
Vascular Diseases
Cardiology
Diabetes
Vascular Disorders
Lipids
Urology
Hematology
MeSH Descriptors
Cardiovascular Agents
Cardiovascular Diseases
Cardiovascular System
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/0115701611508994261012075657
Open DOI
Anti-angiogenic Therapy at the Vascular Crossroads: Tumor Vessel Normalization, Excessive Pruning, and Systemic Vascular Toxicity
Tumor angiogenesis contributes to tumor growth, metastasis, and treatment resistance, but the newly formed vessels are often structurally abnormal and functionally inefficient. Antiangiogenic therapy, particularly inhibition of Vascular ...
02
DOI 10.2174/0115701611519916260928103036
Open DOI
A Review of the Vascular Pathophysiology of Migraine: Should We Consider Statins as a Treatment Option?
Introduction/Objective: Migraine is a primary headache disorder that affects more than a billion people worldwide and can severely impact quality of life. Inflammation and endothelial dysfunction in the trigeminovascular system are the s...
03
DOI 10.2174/0115701611506984260923073428
Open DOI
Efficacy and Safety of Pioglitazone in Improving Cognitive Function Among Stroke Patients: A Prospective, Double-Blind, Randomized Controlled Trial
Introduction: Stroke patients are at a higher risk of developing cognitive difficulties. Insulin resistance has been identified as a risk factor for decline in cognition, raising the possibility that pioglitazone, an insulin-sensitizing ...
04
DOI 10.2174/0115701611491082260918125921
Open DOI
Antithrombotic Therapy in Patients with Chronic Coronary Disease on Anticoagulation: Evidence from Contemporary Trials
Introduction: Chronic coronary disease (CCD) commonly coexists with long-term oral anticoagulation (OAC), particularly for atrial fibrillation (AF). Combination antiplatelet therapy increases bleeding, whereas ischemic protection with OA...
05
DOI 10.2174/0115701611497492260914050320
Open DOI
Balancing the "Faucet" and the "Drain": A Dual-Target Pharmacological Perspective on Fluid Dynamics in High-Altitude Cerebral Edema
High-Altitude Cerebral Edema (HACE) is a potentially fatal microvascular complication caused by severe hypobaric hypoxia. For decades, the pharmacological management of HACE has adopted non-specific systemic drugs to prevent Blood-Brain ...
06
DOI 10.2174/0115701611487581260727114319
Open DOI
Clinical Importance of Albuminuria Reduction in Multimorbid Older Adults with Cardiovascular Disease: SGLT2 Inhibitor Therapy and Implications for Polypharmacy
Background: Albuminuria is a marker of kidney microvascular injury and systemic endothelial dysfunction, linked to kidney and cardiovascular outcomes, particularly Heart Failure (HF). In adults aged ≥75 years with multimorbidity and Card...
07
DOI 10.2174/0115701611457906260714113521
Open DOI
Anticoagulation in the Aging Brain: Navigating the Intersection of Dementia, Cerebrovascular Risk, and Therapeutic Uncertainty
Background: The progressive aging of the global population has been accompanied by a parallel increase in both dementia and atrial fibrillation (AF), two conditions that frequently coexist and are linked through complex cerebrovascular a...
08
DOI 10.2174/0115701611457028260703103439
Open DOI
The Effect of Different Hemodialysis Modalities on Cardiovascular Events and Patients’ Outcomes: A Narrative Review
Hemodialysis (HD) remains the cornerstone of renal replacement therapy for patients with End-Stage Kidney Disease (ESKD). Over the past two decades, conventional HD has been followed by more advanced dialysis modalities, including online...
09
DOI 10.2174/0115701611435345260707064226
Open DOI
Pericarditis/Myopericarditis/Pericardial Effusion: A Contemporary Approach to Diagnosis and Management
Pericarditis is a common disease caused by various factors such as viral infections, systemic diseases, or drugs. A diagnosis of pericarditis is rendered in up to 5% of Emergency Room (ER) visits for non-ischemic chest pain. It is diagno...
10
DOI 10.2174/0115701611514979260706055757
Open DOI
Postprandial Triglycerides and Residual Cardiovascular Risk: Rethinking Lipid-Lowering Strategies
Bibliographical & Catalog Notes
Title from cover.
Also issued online.